Another year, another B!
April 8, 2024 | Carbon Disclosure, Climate change, Pharma, Sustainability, healthcare comms
Louise Jones, Cuttsy+Cuttsy’s Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.
Yes, we’ve been awarded another B rating from Carbon Disclosure Project (CDP)! This is the second-highest rating available from CDP (which monitors environmental impact and risk management) and shows that we have been able to maintain our commitment to sustainability for the past 12 months, resulting in us being rewarded with another top rating!
The past year has been particularly momentous for us; we achieved net zero in both Scopes 1 and 2 (you’ll find more about the scope definitions here), which means we have just Scope 3 to conquer. Scope 3, which encompasses emissions resulting from the entire value chain, represents our last barrier to becoming a net zero company. And while achieving true net zero may be a challenge given the current technological landscape, our commitment is unwavering. We’re absolutely determined to get as close to zero as humanly possible!
Disclosing our progress through CDP is a crucial part of our bigger sustainability strategy, and with two years of experience under our belts, we’re embracing new changes in CDP’s submission structure as we head into 2024.
We’ve definitely encountered some roadblocks along the way. The main one being the complexity and time needed to accurately carbon report.
But there is light – after attending the CDP conference last year, we were given the welcome news of the questionnaire’s re-design, which hugely simplifies the reporting process. Firstly, by improving user-friendliness, and secondly (which is likely to be a very significant and far-reaching change), the merging of the climate, forestry, and water questionnaires. This promises to not only streamline the reporting process but for the likes of yours truly who is tasked with annual reporting, brings huge relief!
These changes are also likely to be big drivers in getting get more companies to participate in the scheme and disclose the details of their sustainability efforts. Because an accurate measurement of everyone’s impact is, after all, the only way to achieve true and effective global change. And CDP are clearly showing their commitment to this critical goal.
As we navigate through these improvements and challenges, Cuttsy+Cuttsy remains steadfast in its commitment to sustainability. And we look forward to making even greater strides in the coming years. Here’s to another year of progress and collective efforts towards a sustainable future.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Cuttsy+Cuttsy welcomes three new experts to the team
Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.
The gap between hype and reality, what patients really say about weight loss drugs
Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.
Why patient-centricity depends on site-centricity in clinical trials
Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.
From cloudy to clear: visualising complex data privacy information
Discover how clear communication principles can transform complex clinical research topics, as we conclude our Health Literacy series with a practical example on participant data transparency.
UK clinical trial regs are changing — here’s what’s happening
Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.
The invisible influence on trial retention: why caregivers must be part of the plan
Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and how to better support them.
Where it all began: why we wrote ‘The Site Factor’
Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.
From text to context: Helping patients see side effects clearly
Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.
Why patient engagement must come first in rare disease trials
Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.
New Cuttsy+Cuttsy research shows why site support matters more than ever
Cuttsy+Cuttsy's upcoming report, 'The site factor: Where protocol meets practice in clinical trials', delves into the critical role of site staff in clinical research, offering insights into their daily challenges,...